Skip to main content
. 2022 Sep 26;72(11):529–540. doi: 10.1111/pin.13272

Figure 2.

Figure 2

Reduced expression of DUSP6 in invasive ductal adenocarcinoma in the pancreas. (a) H & E staining. (b) Immunohistochemistry using a polyclonal anti‐DUSP6 antibody (Santa Cruz Biotechnology Inc.). Both panels are ×200 original magnification.